Delivery Order SPE2DB22D2206-SPE2DB24FFN94
Award Date 2/9/24
Potential Completion Date 3/4/24
Potential Value $30K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $10,784.34 with a completion date of February 4, 2025. It is for the supply of Talzenna 0.5 mg Capsule 30s, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 0.25 mg softgel capsules of the drug Talzenna, with a ceiling value of $11,135.25 and a completion date of June 11, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,784.34 firm fixed-price delivery order is for the supply of TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a $11,135.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.25 mg softgel capsules (30-count units) on September 9, 2025, with a completion date of September 30, 2025. This competitively awarded, non-set-aside order will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,135.25 firm-fixed-price contract is for the delivery of TALZENNA 0.35 MG SOFTGEL 30S, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp for Talzenna 0.5 mg softgels (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract with performance executed from the company's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALZENNA 0.35 MG SOFTGEL 30S, with a ceiling value of $11,135.25 and a period of performance through July 29, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $10,424.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TALZENNA 1 MG CAPSULE 30S pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
- This federal contract award, valued at $10,784.34, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the medical product TALZENNA 0.5 MG CAPSULE 30S, with a performance period ending on March 27, 2025. The contract is a firm fixed-price arrangement, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALZENNA 0.35 MG SOFTGEL 30S, a pharmaceutical product, with a ceiling value of $12,235.91 and a period of performance through May 2, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFN94Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $30,008.88, is for the supply of a specialty medication, Talzenna 1 mg capsule, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This award is issued under a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 5/10/24, 11:33 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.0k | 2/9/24 |